Last 12 months
Inside the activity.
0 purchase rows · 50 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 23 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 22:08 UTC |
MCGIRR DAVID W JDirector
|
Exercise / conversionCommon Stock | 4,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077866 · tm2619022-4_4seq1.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:09 UTC |
JEAN CHRISTOPHEDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-077867 · tm2619022-5_4seq1.xml · derivative · entry 2 JEAN CHRISTOPHE · CIK 0001378435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:09 UTC |
JEAN CHRISTOPHEDirector
|
Exercise / conversionCommon Stock | 4,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077867 · tm2619022-5_4seq1.xml · nonDerivative · entry 1 JEAN CHRISTOPHE · CIK 0001378435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:03 UTC |
Arbuckle Stuart ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-077863 · tm2619022-2_4seq1.xml · derivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:03 UTC |
Arbuckle Stuart ADirector
|
Exercise / conversionCommon Stock | 4,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077863 · tm2619022-2_4seq1.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:06 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-077864 · tm2619022-3_4seq1.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units are fully vested. The restricted stock units have no expiration date. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 22:06 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 4,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077864 · tm2619022-3_4seq1.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:15 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 37,000 | $0.00 Strike: $28.27 | $0.00 |
DisclosureSEC source: 0001104659-26-077305 · tm2618690-1_4seq1.xml · derivative · entry 3 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2030-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:15 UTC |
TETRAULT LYNN A.Director
|
SaleCommon Stock | 37,000 | $100.32 | $3,711,895.50 |
DisclosureSEC source: 0001104659-26-077305 · tm2618690-1_4seq1.xml · nonDerivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,000 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on December 15, 2025. F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $100.00 to $100.91. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:15 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 37,000 | $28.27 | $1,045,990.00 |
DisclosureSEC source: 0001104659-26-077305 · tm2618690-1_4seq1.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:15 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $17.87 | $0.00 |
DisclosureSEC source: 0001104659-26-064516 · tm2615222-1_4seq1.xml · derivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 3,000 shares Expires 2030-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:15 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $17.87 | $53,610.00 |
DisclosureSEC source: 0001104659-26-064516 · tm2615222-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,406 | $0.00 Strike: $17.97 | $0.00 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · derivative · entry 7 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,325 Underlying: Common Stock · 1,406 shares Expires 2033-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,349 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · derivative · entry 6 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,701 Underlying: Common Stock · 1,349 shares Expires 2034-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,687 | $0.00 Strike: $56.69 | $0.00 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · derivative · entry 5 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,713 Underlying: Common Stock · 1,687 shares Expires 2035-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
SaleCommon Stock | 4,643 | $92.21 | $428,131.03 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · nonDerivative · entry 4 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,406 | $17.97 | $25,265.82 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · nonDerivative · entry 3 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,349 | $49.23 | $66,411.27 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · nonDerivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:15 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,687 | $56.69 | $95,636.03 |
DisclosureSEC source: 0001104659-26-063830 · tm2615084-1_4seq1.xml · nonDerivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes an aggregate of 201 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:35 UTC |
Popovits Kimberly JDirector
|
GrantStock Options (Right to Buy) · Derivative | 10,257 | $0.00 Strike: $88.12 | $0.00 |
DisclosureSEC source: 0001104659-26-039685 · tm2611099-2_4seq1.xml · derivative · entry 2 Popovits Kimberly J · CIK 0001333482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,257 Underlying: Common Stock · 10,257 shares Expires 2036-03-31 F3 · derivative.exercise_date: The stock options were granted on April 1, 2026. The options vest and become exercisable in three substantially equal annual installments subject to the Reporting Person continuing in service through each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:35 UTC |
Popovits Kimberly JDirector
|
GrantRestricted Stock Units · Derivative | 6,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-039685 · tm2611099-2_4seq1.xml · derivative · entry 1 Popovits Kimberly J · CIK 0001333482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,808 Underlying: Common Stock · 6,808 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:36 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-039687 · tm2611099-1_4seq1.xml · derivative · entry 3 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. The restricted stock units have no expiration date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:36 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionRestricted Stock Units · Derivative | 10,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-039687 · tm2611099-1_4seq1.xml · derivative · entry 2 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,375 Underlying: Common Stock · 10,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 1, 2026 and April 1, 2027. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 1, 2026 and April 1, 2027. The restricted stock units have no expiration date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:36 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionCommon Stock | 12,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-039687 · tm2611099-1_4seq1.xml · nonDerivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:11 UTC |
Mathers Edward TDirector
|
OtherCommon Stock | 4,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-108351 · ownership.xml · nonDerivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 2 Disclosed balance after: 14,168 F1 · kind: NEA Partners 13, L.P. ("NEA Partners 13") made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 12, 2026. The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 4,199 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 12, 2026. F2 · ownership.nature: The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:51 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $17.97 | $0.00 |
DisclosureSEC source: 0001104659-26-024750 · tm268127-1_4seq1.xml · derivative · entry 3 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,731 Underlying: Common Stock · 1,500 shares Expires 2033-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:51 UTC |
German Christopher PaulCorporate Controller & CAO
|
SaleCommon Stock | 5,614 | $89.56 | $502,789.84 |
DisclosureSEC source: 0001104659-26-024750 · tm268127-1_4seq1.xml · nonDerivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160 F1 · balance_after: Includes 21 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:51 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,500 | $17.97 | $26,955.00 |
DisclosureSEC source: 0001104659-26-024750 · tm268127-1_4seq1.xml · nonDerivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,099 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-26-022440 · tm267814-1_4seq1.xml · derivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,401 Underlying: Common Stock · 6,099 shares Expires 2032-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionCommon Stock | 6,099 | $6.80 | $41,473.20 |
DisclosureSEC source: 0001104659-26-022440 · tm267814-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:40 UTC |
Mathers Edward TDirector
|
OtherCommon Stock | 4,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-091684 · ownership.xml · nonDerivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 2 Disclosed balance after: 9,969 F1 · kind: NEA Partners 13, L.P. ("NEA Partners 13") made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 2, 2026. The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 4,198 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 2, 2026. F2 · ownership.nature: The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:22 UTC |
Mazabraud YannEVP, Head of International
|
GrantStock Options (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $94.94 | $0.00 |
DisclosureSEC source: 0001104659-26-023659 · tm268041-1_4seq1.xml · derivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-03-01 F1 · derivative.exercise_date: The stock options were granted on March 2, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:45 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-023018 · tm267913-1_4seq1.xml · derivative · entry 3 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,162 Underlying: Common Stock · 1,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 1, 2026 and March 1, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 1, 2026 and March 1, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:45 UTC |
German Christopher PaulCorporate Controller & CAO
|
Tax withholdingCommon Stock | 342 | $94.94 | $32,469.48 |
DisclosureSEC source: 0001104659-26-023018 · tm267913-1_4seq1.xml · nonDerivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,253 F2 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:45 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-023018 · tm267913-1_4seq1.xml · nonDerivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 585 | $103.28 | $60,420.44 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 9 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,512 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $103.09 to $103.50 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 800 | $102.10 | $81,676.08 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 8 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,097 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $101.57 to $102.36 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,692 | $100.92 | $170,754.78 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 7 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,897 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.57 to $101.55 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,308 | $100.27 | $131,152.90 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 6 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,589 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $99.55 to $100.54 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 200 | $103.84 | $20,768.00 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 5 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,897 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,069 | $103.00 | $110,109.57 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 4 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,097 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $102.52 to $103.43 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 900 | $101.70 | $91,530.00 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 3 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,166 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $101.45 to $101.88 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 200 | $100.52 | $20,104.00 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,066 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.34 to $100.70 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 02:02 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,200 | $99.42 | $119,298.00 |
DisclosureSEC source: 0001104659-26-017729 · tm266887-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,266 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $99.25 to $99.87 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 21:30 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-017082 · tm266636-1_4seq1.xml · derivative · entry 2 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 21:30 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-017082 · tm266636-1_4seq1.xml · nonDerivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 100 | $100.10 | $10,010.00 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 10 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,466 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 800 | $98.99 | $79,192.48 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 9 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,566 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $98.54 to $99.40 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 400 | $97.67 | $39,068.52 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 8 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,366 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $97.18 to $97.85 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 292 | $96.26 | $28,108.71 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 7 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,766 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $96.04 to $96.58 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.